Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
Pharmacology
Pharmacology for Vet Techs
| Question | Answer |
|---|---|
| What is a drug? | -natural or artificial -if medicinal can be used as a substance to treat, prevent or diagnose a disease -any chemical agent (other than food) |
| What is pharmacology? | -study of drugs or poisons |
| What is pharmacokinetics? | -study of what the body does to the drug -movement in , through and out of body -absorption, metabolism, distribution and excretion |
| What is pharmacodynamics? | -what the drug does to the body -mode of action -dose-response/effect relationship |
| Routes of administration two types? | -enteral-to do with the GI tract -parenteral-other than GI |
| Enteral examples of administration? | -oral-OP -rectal |
| Parenteral examples of administration? | -spinal -IV, SC, IP, IM, IC -intra-dermal (only goes into dermal layer of skin - intra-arterial (joints) -intra-osseous (into bone like tibia) -epidural (into the small of the back) |
| Advantages of Oral administration? | -cheaper -convenient for owner -easy to administer -safest option -pain free -no need for sterile equipment -variety of dose forms -systemic distribution |
| Disadvantages of Oral administration? | -absorption is varied -gastric irritability in some causes vomiting -not used if animal is vomiting or unconscious -patient cooperation and unpleasant taste -slow onset -diluted -may be destroyed by gastric pH, liver enzymes etc. |
| Rectal Administration? | -Suppositories -suspension -good for unconscious or vomiting animals -can cause irritability to rectal mucosa -often erratic and incomplete -if inserted at the terminal end it by passes the portal vein and therefore the 1st part of metabolism |
| Topical Administration? | -to the surface of the mucous membranes or skin (transdermal) |
| Other Enteral Administration? | -endo/intra tracheal (inhalation) -inhalation into the lungs -intramammary-teats or udder |
| Parenteral Considerations? | -injection other than GI considerations: -volume to administer -drug concentration -tonicity -pH -viscosity -particle size -temp -sterility -adjuvants and vasoconstrictions |
| IV injection benefits and disadvantages? | -can deliver large doses -can achieve high concentrations -can titrate "to effect" -100% bioavailable -most hazardous -applicable for some irritant ones -not good for suspensions or oils -use the smallest needle |
| SC and IM considerations? | -speed -duration -pain -complications-swelling -IM don't use unless necessary |
| Intra-dermal injections? | -allergy tests -can only inject small volumes |
| Intra-osseous injections? | -direct into bone marrow -give if cant use IV |
| Intra-cardiac? | -only use for emergencies, e.g. like adrenaline |
| Intra-articular? | -e.g. arthritis for horses -morphine -corticosteroids -local anaesthesia -(relates to joints) |
| Intra-peritoneal advantages? | -larger absorptive area -better bloody supply than IM & SC -in small animals can give crystalloids and anesthetic drugs through |
| Intra-peritoneal disadvantages? | -may cause peritonitis -too much may restrict breathing -potential for discomfort -damage to organs by needles -cant use for euthanasia |
| Epidural injections? | -can give local anesthesia or opioids like morphine -space between L7-sacrum with no vertebrae |
| Spinal injections? | -injected into the cerebrospinal fluid -local anesthetics and opioids -smaller volume -faster onset -shorter duration |
| Other routes for injections? | -intra-tracheal-through tube, local or systemic effect like adrenaline -inhalation-absorption through lungs, e.g. anti-asthmatics, inhalation anesthesia -sublingual-under the tongue, not oral, goes into mucosal layer and directly into blood |
| Topical Administration? | -mucous membranes-local effects, ear nose eye, desensitization of laryx with lignocaine, vagine uterus or urethra -skin/transdermal: ointment or lotion, local action, e.g. neomycin, transdermal-absorption through skin e.g. fentanyl patch, hormones |
| Drug absorption? | -movement of the drug from the site of administration to the body by blood, lymph or extra/intra cellular environment -absorption rate constant (ka) is the amount of drug that is absorbed into the body as a set amount of time |
| Factors affecting rate of absorption? | -physiological-associated with route of administration -for oral-membrane physiology and GI physiology -factors associated with properties of drug-molecular weight, pH, solubility, ionization -membrane permeability -dosage form |
| More factors affecting rate of absorption? | -whether it goes into blood or lymph -whether it is a weak acid (absorption best in stomach)or weak base (absorption best in intestine) -oral-goes into blood and then portal vein or lymph (if lipid soluble) then to the liver where some/all metabolised |
| Rate of Absorption-parenteral? | depends on: -condition of injected site -degree of tissue perfusion -properties of the drug-IM is quicker, ID-slower |
| Rate of Absorption-other routes? | -topical-less absorption-increases if broken -rectal and sublingual-absorption fast due to vascularity mucosa |
| Passive diffusion?-drug transport | -goes down concentration gradient -weak acids/bases are either ionized or non-ionized -non ionized are lipid soluble and diffuse |
| Drug transport-facilitated diffusion and active transport? | -facilitated same as passive but with the help of a carrier protein -active-needs help of carrier protein and ATP-as goes against concentration gradient, e.g. transport of drug to urine or transport of bile-drug |
| pinocytosis and phagocytosis-drug transport? | -engulf drug -needs ATP |
| First Pass effect? | -intestine/hepatic metabolism when delivered by portal circulation -greater-less drug that reaches systemic circulation |
| Drug Distribution? | -process by which it leaves injection site (parenteral) or liver (enteral) and circulates in body |
| Types of Drug Distribution? | -stays in vascular system-large or bound-plasma proteins -distributed body water-small gases -concentrates specific tissue-iodine thyroid -throughout body/tissue-common, determined by ability to pass through membrane, highest in organs of elimination |
| What is drug distribution influenced by? | -local blood flow -ability to bind to plasma/tissue proteins -some can change their own distribution-anesthetics -ability to cross biological membranes |
| Why do drugs bind to plasma proteins and what are the important ones? | Drugs bind to proteins to be transported and distributed. -important ones: albumin, acid glycoproteins and beta globulins |
| Drug binding to Protein? | -reversible -forms a reservoir (inactive) -obeys law of mass action -KD<1- high affinity -KD>1-low affinity |
| Disease or pregnant patients in relation to protein bound drugs? | -need to adjust level of protein bound drugs due to changes in plasma protein levels |
| Overdose risk with drugs? | -too much free drugs, when they compete for the same plasma protein they displace each-other and re-bounce |
| Drug Elimination-2 processes? | -metabolism and excretion -aim to increase their polarity (water solubility) as most are lipophilic-poorly excreted by kidney and liver |
| Organs involved in drug metabolism? | -liver -small intestine -kidneys -skin -lungs -plasma -other |
| Cytosol involved in drug metabolism? | -mitochondria -lysosomes -smooth ER |
| Phase 1 Metabolism?- drugs | -oxidation (with oxidases) -reduction (with reductases) -hydration (with hydrolases) -polar drugs are excreted and non polar are made more polar -reduces therapeutic activity of drugs-some still active, some toxic, pro-drugs bio-activated |
| Phase 2 Metabolism?- drugs | -involves transferase enzymes -drugs undergo conjugation (ionized molecules added e.g. acetyl, methyl) to form a conjugate (polar molecule) which can then be excreted |
| Some drugs can alter their metabolism, how? | -by inhibiting or inducing enzyme synthesis -so dose rates then need to be increased or decreased to maintain effective plasma concentrations. |
| factors that affect liver metabolism? | -age -disease -diet -environment -physiological status -other drugs -genetics -route of administration |
| Metabolism & entero-hepatic circulation? | -metabolized drug is excreted in bile -goes into intestinal lumen (where bacteria deconjugate it into a free drug) -is re-absorbed across intestinal mucosa -portal circulation goes back to liver -this delays its elimination and it can accumulate |
| What does bioavailable mean? | -measure of drug absorption, the rate that it is taken up in an active form |
| Drug Secretion? | -urine (kidney,renal), active process -bile (liver), active process -other (saliva, tear, sweat), minor, passive diffusion -lungs (for volatile drugs) -excretion in milk (dairy animals) |
| Renal secretion? | -nephron -glomerular filtration -tubular secretion -tubular reabsorption |
| Glomerular filtration? | -small molecules that dissolve in plasma water are excreted by passive elimination -free drugs <20kDa are sieved in water, ionized or unionized -plasma protein bound cannot be filtered |
| Tubular Secretion? | -active transport -acid and basic carriers -excreted by proximal tubule -slower elimination -competition between drugs for same transporters -separate transport system for acids/bases -acid-penicillin -base-dopamine |
| Tubular Reabsorption-active? | -involves energy -mainly occurs in the proximal tubule -endogenous compounds-AA, glucose, Na, K -renal tubule to the blood -drugs-similar to AA are reabsorbed -induces passive reabsorption of water |
| Tubular Reabsorption-passive? | -goes into blood -down concentration gradient -non ionized drugs and H20 reabsorbed -ionizing stay in urine -depends on pKa and pH -elimination can be modified by urine pH -e.g. phenobarbital elimination increased by alkalizing urine as pKa 7.2 |
| Excretion in bile? | -large polar molecules >300kDa -as they cannot pass the membrane -may enter entero-hepatic circulation -good (dogs), moderate (cats), poor (humans) |
| Pharmacokinetic important parameters? | -bioavailability (F)-absorption -volume of distribution (Vd)-distribution -plasma half life (T1/2)-elimination -clearance (CL)-elimination |
| Bioavailability? | -plots plasma concentration vs. time -is the amount of dose that can reach the bloodstream and is physiologically active -for IV is 100% -for oral is % under curve compared to that under IV curve |
| Bioavailability example? | e.g. cyclosporine bioavailable IV = 100% bioavailable PO = 0.25/25% so oral dose = 4 * IV dose |
| Factors influencing bioavailability? | -route of admin -differences in species e.g. mono vs poly gastrics |
| Volume of Distribution? | -volume of fluid into which the drug is dispersed to the body at a uniform concentration -fluids tissues-highly perfused by blood -Vd = dose of drug/concentration of drug small-high conc plasma retention large-low conc plasma retention outside plasma |
| Vd examples? | Vd-3-restricted to plasma eg heparin Vd-11-distributed in ECF but cant go into cells e.g. mannitol Vd-42-penetrate most barriers, total water body both ECF and ICF e.g. alcohol Vd>24-extensively stored in specific areas eg. chloroquine |
| Drug half life, what does this mean? | -time it takes for the amount of drug in the body to be reduced by half -T 1/2 = 0.693/kei -kei is elimination rate constant -depends on Vd and CL -dose does not change -varies between individuals as each has their own T1/2 for each drug |
| What is body clearance? | -rate of elimination in relation to drug conc in plasma =rate of elimination/concentration -vol plasma cleared of drug/unit time -factor influence-urine pH, diseases & plasma protein binding |
| Clinical Pharmacokinetics? | -studies time course of a drug concentration in the body -drug conc can be measure in urine, plasma, cerebrospinal fluid etc. -if know dose and conc, can measure the parameters |
| What is a steady state-drug? | -amount of drug entering body=to amount of drug leaving body -steady after 4 half lives -accumulates if not eliminated before next dose |
| Why do we need to know pharmacokinetic parameters? | -bioavailability-measures unchanged drug that goes to circulation -Vd-measure amt of drug in body fluid both determine dose size -T 1/2- determines steady state and dosing interval -CL- determines dose rate |
| Dosage form? | -formulation of the prepared drug |
| Dose? | -amt of drug given per time unit |
| daily dose? | -calculated from dose and no. per day |
| dosing rate? | -dose/time |
| dosage regimen? | -freq. drug doses including time period and intervals |
| Initial/loaded or priming dose | -large single dose before later smaller doses |
| Maintenance doses | smaller, equal doses given at intervals |
| prophylactic doses | given to prevent getting a disease |
| therapeutic doses | given after exposure to an illness |
| Pharmacodyamic considerations? | -mode of action (action site and mechanism) -drug effect (final effect) |
| Why are we concerned about how drugs work? | -when applying QLD health drug and poisons regulations 1996 -to know adverse effects and contraindications -approved uses |
| How do drugs work? | -non receptor-by its properties -receptor-binds in or on cells -by enzymes-target and blocks reactions |
| Non-receptor drugs method? | -chemical action e.g. antacids neutralize gastric acid secretion -physical-osmosis (mannitol), purgatives, lubricant (paraffin), adsorbent (charcoal), demulcent |
| Receptor mediated drugs? | -bind to membrane receptors-on cell surfaces -intracellular receptors-in nucleus or cytoplasmicorganelles -receptors are molecules that bind to specific molecules (ligands) -cellular receptors (membrane) -nuclear receptors (intracellular) |
| Drug-Receptor interactions? | -lock and key -depends on drug structure -if weak-h bonds & van der waal-short acting -if strong-covalent bonds-long acting |
| Examples of receptor drugs | -fentanyl-acts on membrane receptors -local anesthetics-on ion channels -erythromycin & aminoglycosides-on cytoplasmic structures -steroids & thyroid hormones-on intracellular receptors |
| Enzyme drugs? | -inhibit enzymes and stop their biochemical processes -aspirin stops prostaglandins act in inflammation |
| Drugs that inhibit carrier proteins? | -e.g. loop diuretics-furosemide inhibits on Na/K/Cl pump, causes loss of water and sodium and they are not reabsorbed |
| What are agonists? | -they bind to and activate receptors to cause an effect |
| What are antagonists? | -bind and block receptors from agonist activity |
| Competitive Antagonist? | -competes with the agonist/ligand for the same binding site, reversible if give a large dose of agonist |
| Non Competitive Antagonist? | -binds to a different site to the agonist and inhibits the biological function of the receptor, irreversible |
| Dose-response drug relationships? | -low dose-no response -increase dose, increase response -maximum response, when adding more dose has no effect ED50-when drug produces 50% of its maximum effect LD50-lethal dose that kills 50% population in a set time of exposure |
| Therapeutic Index? | -ratio between a dosage being lethal to being therapeutic =TD50/ED50 -measures drug safety -high ED, more safe |
| Variability in drug response? | 1. biological system (age, status, gender, weight etc. 2. drug & admin (route, dose, formulation, repeated-allergy,resistence) 3. drug interactions (chemical or physical, during metabolism, receptor level, excretion level, protein binding level) |
| Drug Classification? | -structure -system it effects -physiological effect -pathological effect -their use -legislation |
Created by:
sherloki
Popular Veterinary sets